Elanco Animal Health Incorporated Gain (Loss) on Disposition of Other Assets
Elanco Animal Health Incorporated (ELAN) reported Gain (Loss) on Disposition of Other Assets of -$1.00 million for the 3-month period ending 2023-03-31, per its 10-Q filed 2023-05-09.
Discontinued › Income Statement › Other Income
us-gaap:GainLossOnSaleOfOtherAssets · last filed 2023-05-09
- Elanco Animal Health Incorporated gain (loss) on disposition of other assets for the quarter ending 2023-03-31 was -$1.00M.
- Elanco Animal Health Incorporated gain (loss) on disposition of other assets for the quarter ending 2022-12-31 was -$2.00M.
- Elanco Animal Health Incorporated gain (loss) on disposition of other assets for the quarter ending 2022-09-30 was -$2.00M, a 200.00% decline year-over-year.
- Elanco Animal Health Incorporated gain (loss) on disposition of other assets for the quarter ending 2022-06-30 was $0.00.
- Elanco Animal Health Incorporated gain (loss) on disposition of other assets for fiscal 2022 was -$5.00M.
- Elanco Animal Health Incorporated gain (loss) on disposition of other assets for fiscal 2021 was -$4.00M, a 107.84% decline from fiscal 2020.
- Elanco Animal Health Incorporated gain (loss) on disposition of other assets for fiscal 2020 was $51.00M.
- Elanco Animal Health Incorporated gain (loss) on disposition of other assets for fiscal 2019 was $0.00, a 100.00% decline from fiscal 2018.
| Period end | Gain (Loss) on Disposition of Other Assets 3 month | Gain (Loss) on Disposition of Other Assets 6 month | Gain (Loss) on Disposition of Other Assets 9 month | Gain (Loss) on Disposition of Other Assets 9 month as first filed | Gain (Loss) on Disposition of Other Assets 12 month | Gain (Loss) on Disposition of Other Assets 12 month as first filed |
|---|---|---|---|---|---|---|
| 2023-03-31 | -$1.00M 10-Q · filed 2023-05-09 | -$3.00M derived: sum of 2 quarters · filed 2023-05-09 | -$5.00M derived: sum of 3 quarters · filed 2023-05-09 | -$5.00M derived: sum of 4 quarters · filed 2023-05-09 | ||
| 2022-12-31 | -$2.00M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-01 | -$4.00M derived: sum of 2 quarters · filed 2023-03-01 | -$4.00M derived: sum of 3 quarters · filed 2023-03-01 | -$5.00M 10-K · filed 2023-03-01 | ||
| 2022-09-30 | -$2.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-08 | -$2.00M derived: sum of 2 quarters · filed 2022-11-08 | -$3.00M 10-Q · filed 2022-11-08 | -$7.00M derived: sum of 4 quarters · filed 2023-05-09 | ||
| 2022-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-08 | -$1.00M 10-Q · filed 2022-08-08 | -$5.00M derived: sum of 3 quarters · filed 2023-05-09 | -$3.00M derived: sum of 4 quarters · filed 2023-05-09 | ||
| 2022-03-31 | -$1.00M 10-Q · filed 2023-05-09 | -$5.00M derived: sum of 2 quarters · filed 2023-05-09 | -$3.00M derived: sum of 3 quarters · filed 2023-05-09 | -$5.00M derived: sum of 4 quarters · filed 2023-05-09 | ||
| 2021-12-31 | -$4.00M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-01 | -$2.00M derived: sum of 2 quarters · filed 2023-03-01 | -$4.00M derived: sum of 3 quarters · filed 2023-03-01 | -$4.00M 10-K · filed 2023-03-01 | ||
| 2021-09-30 | $2.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-08 | $0.00 derived: sum of 2 quarters · filed 2022-11-08 | $0.00 10-Q · filed 2022-11-08 | $0.00 derived: sum of 4 quarters · filed 2023-03-01 | ||
| 2021-06-30 | -$2.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-08 | -$2.00M 10-Q · filed 2022-08-08 | -$2.00M derived: sum of 3 quarters · filed 2023-03-01 | -$2.00M derived: sum of 4 quarters · filed 2023-03-01 | ||
| 2021-03-31 | $0.00 10-Q · filed 2022-05-09 | $0.00 derived: sum of 2 quarters · filed 2023-03-01 | $0.00 derived: sum of 3 quarters · filed 2023-03-01 | $47.00M derived: sum of 4 quarters · filed 2023-03-01 | ||
| 2020-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-01 | $0.00 derived: sum of 2 quarters · filed 2023-03-01 | $47.00M derived: sum of 3 quarters · filed 2023-03-01 | $51.00M 10-K · filed 2023-03-01 | $51.30M 10-K · filed 2021-03-01 | |
| 2020-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-05 | $47.00M derived: sum of 2 quarters · filed 2021-11-05 | $51.00M 10-Q · filed 2021-11-05 | $51.30M 10-Q · filed 2020-11-06 | $51.00M derived: sum of 4 quarters · filed 2022-02-28 | |
| 2020-06-30 | $47.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-09 | $51.00M 10-Q · filed 2021-08-09 | $51.00M derived: sum of 3 quarters · filed 2022-02-28 | |||
| 2020-03-31 | $4.00M 10-Q · filed 2021-05-07 | $4.00M derived: sum of 2 quarters · filed 2022-02-28 | ||||
| 2019-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-28 | $0.00 10-K · filed 2022-02-28 | ||||
| 2019-09-30 | $0.00 10-Q · filed 2020-11-06 | |||||
| 2018-12-31 | $800.00K 10-K · filed 2021-03-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| MADRIGAL PHARMACEUTICALS, INC. (MDGL) | United States | $11.859B | -38.17 |
| BIOMARIN PHARMACEUTICAL INC (BMRN) | United States | $11.879B | 151.80 |
| Axsome Therapeutics, Inc. (AXSM) | United States | $10.274B | -66.82 |
| CORCEPT THERAPEUTICS INC (CORT) | United States | $12.804B | 169.10 |
| BridgeBio Pharma, Inc. (BBIO) | United States | $12.947B | -20.72 |
| ARROWHEAD PHARMACEUTICALS, INC. (ARWR) | United States | $9.331B | -42.28 |
| Summit Therapeutics Inc. (SMMT) | United States | $13.071B | -13.21 |
| CYTOKINETICS INC (CYTK) | United States | $9.130B | -11.86 |
| Protagonist Therapeutics, Inc (PTGX) | United States | $8.883B | 95.52 |
| TG THERAPEUTICS, INC. (TGTX) | United States | $8.805B | 19.05 |